SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 25 micrograms/25 micrograms, injectable dispersion. mRNA vaccine against COVID-19 10 bottles
Active ingredients: DAVESOMÉRAN, ÉLASOMÉRAN
Commercialized according to BDPMDispensing in France: Prescription only
Injectable dispersion10 bottlesintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 25 microgrammes/25 microgrammes, dispersion injectable. Vaccin à ARNm contre la COVID-19
- Pharmaceutical form
- dispersion injectable
- Route of administration
- intramusculaire
- Presentation description
- 10 flacon(s) unidose(s) en verre (10 doses)
- Marketing authorisation holder
- MODERNA BIOTECH SPAIN SL (ESPAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Oct 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
69556437CIP73026647CIP133400930266472Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉLASOMÉRANdispersion | 25 microgrammes · une dose de 0,5 mL | SA |
| DAVESOMÉRANdispersion | 25 microgrammes · une dose de 0,5 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.